Literature DB >> 6604031

Sodium butyrate produces concordant expression of "early placental" alkaline phosphatase, pregnancy-specific beta 1-glycoprotein and human chronic gonadotropin beta-subunit in a newly established uterine cervical cancer cell line (SKG-IIIa).

S Nozawa, E Engvall, S Kano, S Kurihara, W H Fishman.   

Abstract

The production of early and term placental alkaline phosphatase (ALP), human chorionic gonadotropin beta-subunit (beta-hCG) and pregnancy-specific beta 1-glycoprotein (SP1) was confirmed in the newly established uterine cervical cancer call line SKG-IIIa. Treatment of these cells in culture with sodium butyrate caused an increase of all of these oncodevelopmental proteins. On the other hand, prednisolone treatment enhanced only term placental ALP, while it reduced early placental ALP, beta-hCG and SP1. These data suggested that such oncotrophoblastic proteins as early placental ALP, beta-hCG and SP1 were concordantly modulated by butyrate and prednisolone. These findings may support the possibility of the reexpression of sets of development phase-specific genes in cancer cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604031     DOI: 10.1002/ijc.2910320302

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Human pregnancy-specific beta 1 glycoprotein is encoded by multiple genes localized on two chromosomes.

Authors:  W Y Chan; W R Qiu
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

2.  Infantile hypophosphatasia: enzymatic defect explored with alkaline phosphatase-deficient skin fibroblasts in culture.

Authors:  M P Whyte; S D Rettinger; L A Vrabel
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

Review 3.  Alkaline phosphatase isozymes in cultured human cancer cells.

Authors:  F Herz
Journal:  Experientia       Date:  1985-11-15

4.  Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5.

Authors:  T Nakagawa; Y Nakao; T Matsui; T Koizumi; S Matsuda; S Maeda; T Fujita
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

5.  Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.

Authors:  Y Sidi; C Panet; L Wasserman; A Cyjon; A Novogrodsky; J Nordenberg
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.